Rischin, D., Migden, M. R., Chang, A. L. S. and al., E. (2018) “Primary Analysis of Phase 2 Results for Cemiplimab, a Human Monoclonal Anti-PD-1, in Patients with Metastatic Cutaneous Squamous Cell Carcinoma”, SKIN The Journal of Cutaneous Medicine, 2, p. S79. doi: 10.25251/skin.2.supp.79.